Status:
UNKNOWN
Pelvic Fractures and Radiation Therapy for Cervical Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Cervical Cancer
Endometrial Cancer
Eligibility:
FEMALE
Brief Summary
The goal of this study is to estimate how often pelvic fractures occur in women treated with radiation therapy for either newly diagnosed or recurrent cervical, endometrial, or vaginal cancer. The stu...
Detailed Description
If you agree to take part in this study, the following tests and procedures will be performed before radiation therapy: * You will have a bone mineral density test. A bone mineral density test measur...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed primary or recurrent cervical , endometrial or vaginal cancer. All stages, grades and histologic subtypes will be eligible except neuroendocrine.
- Patients treated with definitive radiation therapy. Patients receiving extended field radiation or brachytherapy in addition to pelvic radiation are eligible. Patients treated with surgery, chemotherapy and/or hormonal therapy in addition to radiation therapy are also eligible.
- Patients must sign an approved informed consent document.
Exclusion
- Patients undergoing palliative intent radiation therapy for advanced disease.
- Patients who received prior radiation to the pelvis.
- Patients with an existing pelvic fracture within the proposed radiation field.
- Patients unwilling or unable to provide informed consent for the study.
- Patients with bone metastases.
- Neuroendocrine features present.
- Patients weighing more than 300 lbs are excluded as they cannot be adequately studied in axial skeleton with current bone mineral density software.
Key Trial Info
Start Date :
November 5 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT00800644
Start Date
November 5 2008
End Date
November 30 2020
Last Update
January 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030